Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00733200|
Recruitment Status : Completed
First Posted : August 12, 2008
Last Update Posted : December 11, 2009
|Condition or disease||Intervention/treatment||Phase|
|Cholangiocarcinoma Surgical Treatment Hepatectomy||Procedure: Minor or Major Liver Resection||Not Applicable|
Objective: To determine the safety and efficacy of minor and major hepatectomy selected by predetermined criteria in patients with hilar cholangiocarcinoma (HC).
Summary Background Data: For HC treated with hepatectomy, the extent of liver resection remains controversial despite extensive studies.
Methods: From January 2000 to December 2007, we prospectively studied patients who received surgical treatment for HC. Of the 187 patients who were surgically treated, 138 (73.8%) underwent resection with a curative intent. Minor hepatectomy was carried out in 93 patients who had Bismuth-Corlette types I, II and III HC without hepatic artery/portal vein invasion; and major hepatectomy in 45 patients who had type III HC with hepatic artery/portal vein invasion, or type IV HC.
|Study Type :||Interventional (Clinical Trial)|
|Official Title:||Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection?|
|No Intervention: Control group||Procedure: Minor or Major Liver Resection|
- On multivariate analysis, prognostic factors significantly impacted on long-term survival were UICC tumor stage and histopathologic grade.